TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is redundant for activating the RIG-I pathway
暂无分享,去创建一个
P. Digard | Nikki Smith | E. Gaunt | G. Michlewski | Nila Roy Choudhury | M. Trubitsyna | Ivan Trus | Magdalena Wołczyk | Gregory Heikel | J. Szymanski | Agnieszka A Bolembach | R. M. Dos Santos Pinto | Agnieszka Bolembach
[1] P. Digard,et al. Compositional biases in RNA viruses: Causes, consequences and applications , 2021, Wiley interdisciplinary reviews. RNA.
[2] S. Neil,et al. Targeted Restriction of Viral Gene Expression and Replication by the ZAP Antiviral System. , 2021, Annual review of virology.
[3] Elizabeth J. Fay,et al. Segment-Specific Kinetics of mRNA, cRNA, and vRNA Accumulation during Influenza Virus Infection , 2021, Journal of Virology.
[4] G. Michlewski,et al. TRIM25 and its emerging RNA‐binding roles in antiviral defense , 2020, Wiley interdisciplinary reviews. RNA.
[5] Laura F. Dagley,et al. RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses , 2019, Immunology and cell biology.
[6] Luis Carrasco,et al. System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection , 2019, Molecular cell.
[7] Jessica J. Chiang,et al. TRIM25 Binds RNA to Modulate Cellular Anti-viral Defense. , 2018, Journal of molecular biology.
[8] Michiel van Gent,et al. TRIM Proteins and Their Roles in Antiviral Host Defenses. , 2018, Annual review of virology.
[9] M. Binder,et al. Ubiquitin-Dependent and -Independent Roles of E3 Ligase RIPLET in Innate Immunity , 2019, Cell.
[10] S. Cusack,et al. Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition , 2018, Nature Communications.
[11] J. Bresee,et al. Advances in measuring influenza burden of disease , 2018, Influenza and other respiratory viruses.
[12] R. Krug,et al. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. , 2017, Cell host & microbe.
[13] Juri Rappsilber,et al. RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination , 2017, bioRxiv.
[14] P. Bieniasz,et al. CG-dinucleotide suppression enables antiviral defense targeting non-self RNA , 2017, Nature.
[15] M. Amorim,et al. Influenza A Virus NS1 Protein Promotes Efficient Nuclear Export of Unspliced Viral M1 mRNA , 2017, Journal of Virology.
[16] Fan Tu,et al. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein , 2017, Journal of Virology.
[17] Eugen C. Buehler,et al. TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP) , 2017, PLoS pathogens.
[18] P. Lemey,et al. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis , 2016, Antimicrobial Agents and Chemotherapy.
[19] B. Sankaran,et al. Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway , 2016, Cell reports.
[20] D. Gubler,et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness , 2015, Science.
[21] Yan Zhou,et al. Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction , 2015, Journal of Virology.
[22] J. Rappsilber,et al. Trim25 Is an RNA-Specific Activator of Lin28a/TuT4-Mediated Uridylation , 2014, Cell reports.
[23] A. García-Sastre,et al. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. , 2014, Journal of molecular biology.
[24] D. Smee,et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.
[25] Jeroen Krijgsveld,et al. The RNA-binding protein repertoire of embryonic stem cells , 2013, Nature Structural &Molecular Biology.
[26] Adolfo García-Sastre,et al. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. , 2013, Immunity.
[27] R. Albrecht,et al. Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein , 2012, PLoS pathogens.
[28] Norman E. Davey,et al. Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins , 2012, Cell.
[29] A. Vazquez,et al. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors , 2012, BMC Biology.
[30] C. Basler,et al. Molecular mechanisms of viral inhibitors of RIG-I-like receptors. , 2012, Trends in microbiology.
[31] S. Cusack,et al. Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA , 2011, Cell.
[32] G. Kochs,et al. The Viral Nucleoprotein Determines Mx Sensitivity of Influenza A Viruses , 2011, Journal of Virology.
[33] Kazuhiro Iwai,et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. , 2011, Molecular cell.
[34] R. Krug,et al. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. , 2010, Virology.
[35] Zhijian J. Chen,et al. Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity , 2010, Cell.
[36] A. Schmidt,et al. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I , 2009, Proceedings of the National Academy of Sciences.
[37] Osamu Takeuchi,et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.
[38] S. Inoue,et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. , 2009, Cell host & microbe.
[39] Osamu Takeuchi,et al. Innate immunity to virus infection , 2009, Immunological reviews.
[40] Osamu Takeuchi,et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity , 2007, Nature.
[41] G. Kochs,et al. Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.
[42] Stefan Hippenstiel,et al. IFNβ induction by influenza A virus is mediated by RIG‐I which is regulated by the viral NS1 protein , 2007, Cellular microbiology.
[43] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[44] A. Osterhaus,et al. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. , 2004, Virus research.
[45] A. García-Sastre,et al. A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice , 2003, Journal of Virology.
[46] C. Samuel,et al. Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.
[47] A. García-Sastre,et al. Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.
[48] G. Montelione,et al. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. , 1999, RNA.
[49] N. Mcferran,et al. Dinucleotide and stop codon frequencies in single-stranded RNA viruses. , 1997, The Journal of general virology.
[50] T. Schlake,et al. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. , 1994, Biochemistry.
[51] S Karlin,et al. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? , 1994, Journal of virology.
[52] E. Yángüez,et al. Propagation and Titration of Influenza Viruses. , 2018, Methods in molecular biology.